Bellerophon Therapeutics, Inc. (BLPH)

Bellerophon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	4.38	6.92	24.74	47.56	9.87	16.65
Cash & Cash Equivalents	4.38	6.92	24.74	47.56	9.87	16.65
Cash Growth	-61.28%	-72.01%	-47.99%	381.64%	-40.68%	-47.69%
Other Current Assets	0.6	0.64	0.72	0.52	0.51	0.75
Total Current Assets	4.98	7.56	25.46	48.08	10.38	17.4
Property, Plant & Equipment	0	0.19	0.93	1.67	2.43	0.66
Other Long-Term Assets	0	0.19	0.49	0.49	0.3	0.3
Total Long-Term Assets	0	0.37	1.42	2.16	2.73	0.96
Total Assets	4.98	7.94	26.88	50.24	13.11	18.36
Accounts Payable	0.61	1.23	1.19	3.73	3.11	2.76
Current Debt	0	0.2	0.75	0.7	0.66	0
Other Current Liabilities	0.64	3.97	3.11	6	3.82	4.78
Total Current Liabilities	1.26	5.4	5.05	10.43	7.58	7.54
Long-Term Debt	0	0	0.2	0.96	1.66	0
Other Long-Term Liabilities	0	1.43	0	0.6	0.27	6.97
Total Long-Term Liabilities	0	1.43	0.2	1.56	1.93	6.97
Total Liabilities	1.26	5.4	5.26	11.99	9.52	14.5
Total Debt	0	0.2	0.96	1.66	2.32	0
Debt Growth	-	-78.74%	-42.47%	-28.36%	-	-
Common Stock	0.12	0.1	0.1	0.1	0.05	0.59
Retained Earnings	-256.32	-252.08	-232.25	-214.49	-189.76	-176.5
Shareholders' Equity	3.72	2.53	21.62	38.25	3.59	3.86
Total Liabilities and Equity	4.98	7.94	26.88	50.24	13.11	18.36
Net Cash / Debt	4.38	6.72	23.78	45.9	7.56	16.65
Net Cash / Debt Growth	-59.88%	-71.74%	-48.19%	507.34%	-54.60%	-47.69%
Net Cash Per Share	0.36	0.70	2.50	5.89	1.68	3.84
Working Capital	3.72	2.16	20.41	37.65	2.8	9.86
Book Value Per Share	0.30	0.27	2.28	4.91	0.80	0.89

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.